Insights Into Kaposi Sarcoma-Associated Herpesvirus-Specific Humoral Responses

Area of Science:

• Immunology
• Virology
• Oncology

Background:

• Kaposi sarcoma (KS) is a significant global health issue, particularly in sub-Saharan Africa with high HIV-1 prevalence.
• The KS-associated herpesvirus (KSHV) is the causative agent of KS, and its prevalence is high in coinfected populations.
• Antiretroviral therapy (ART) has reduced but not eliminated KS and other KSHV-associated malignancies in people living with HIV.

Purpose of the Study:

• To review current knowledge on the KSHV-specific humoral immune response in infected individuals.
• To discuss the role of anti-KSHV antibodies in pathogenesis and therapy.
• To explore KSHV's strategies for evading and manipulating humoral immunity.

Main Methods:

• Literature review of existing research on KSHV humoral immunity.
• Analysis of KSHV's immune evasion mechanisms.
• Evaluation of serological assays and bioinformatics tools for vaccine development.

Main Results:

• The humoral immune response to KSHV is complex and plays a critical role in infection control.
• KSHV employs sophisticated mechanisms to subvert and modulate the host's humoral immunity.
• Advanced serological and bioinformatics tools are essential for understanding KSHV immunity.

Conclusions:

• A deeper understanding of KSHV humoral immunity is vital for managing KS and related diseases.
• Targeting the humoral response may offer new therapeutic strategies.
• Developing effective KSHV vaccines requires comprehensive knowledge of antibody responses and viral immune evasion tactics.